tiprankstipranks
Astrana Health Inc. (ASTH)
NASDAQ:ASTH
US Market
ASTH
Astrana Health
RESEARCH TOOLSreports
Want to see ASTH full AI Analyst Report?

Astrana Health (ASTH) Ratios

270 Followers

Astrana Health Ratios

ASTH's free cash flow for Q1 2026 was $0.09. For the 2026 fiscal year, ASTH's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.35 1.40 1.75 2.11 2.88
Quick Ratio
 1.35 1.40 1.75 2.11 2.88
Cash Ratio
 0.64 0.70 0.79 1.34 1.94
Solvency Ratio
 0.05 0.04 0.08 0.15 0.15
Operating Cash Flow Ratio
 0.22 0.19 0.14 0.31 0.55
Short-Term Operating Cash Flow Coverage
 3.00 2.06 5.57 3.50 132.68
Net Current Asset Value
$ -777.27M$ -797.01M$ -202.23M$ -61.09M$ 20.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.45 0.49 0.35 0.34 0.24
Debt-to-Equity Ratio
 1.33 1.38 0.66 0.52 0.42
Debt-to-Capital Ratio
 0.57 0.58 0.40 0.34 0.30
Long-Term Debt-to-Capital Ratio
 0.55 0.56 0.37 0.30 0.27
Financial Leverage Ratio
 2.95 2.85 1.90 1.52 1.78
Debt Service Coverage Ratio
 1.14 1.03 2.61 2.58 8.34
Interest Coverage Ratio
 1.47 1.57 2.70 5.25 13.16
Debt to Market Cap
 0.55 0.86 0.29 0.15 0.15
Interest Debt Per Share
 23.01 22.99 10.59 7.22 5.28
Net Debt to EBITDA
 3.94 5.22 1.29 0.22 -0.52
Profitability Margins
Gross Profit Margin
9.31%9.30%13.34%15.50%17.43%
EBIT Margin
2.68%2.47%5.60%7.64%8.26%
EBITDA Margin
4.22%3.91%6.97%8.92%9.80%
Operating Profit Margin
2.45%2.47%4.39%6.10%9.11%
Pretax Profit Margin
1.41%1.24%3.97%6.48%7.57%
Net Profit Margin
0.86%0.71%2.12%4.38%3.95%
Continuous Operations Profit Margin
0.88%0.76%2.45%4.17%4.00%
Net Income Per EBT
60.81%56.78%53.39%67.58%52.15%
EBT Per EBIT
57.49%50.44%90.45%106.18%83.07%
Return on Assets (ROA)
1.28%1.01%3.18%6.51%4.68%
Return on Equity (ROE)
3.88%2.89%6.05%9.89%8.33%
Return on Capital Employed (ROCE)
5.36%4.90%9.03%11.84%12.75%
Return on Invested Capital (ROIC)
3.23%2.88%5.50%7.37%6.70%
Return on Tangible Assets
2.46%2.07%5.28%10.42%7.28%
Earnings Yield
1.62%1.85%2.87%3.35%3.39%
Efficiency Ratios
Receivables Turnover
 7.05 7.81 6.26 9.39 9.56
Payables Turnover
 14.45 818.95 116.24 129.11 90.20
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 37.72 33.69 43.40 31.11 8.87
Asset Turnover
 1.50 1.43 1.50 1.49 1.18
Working Capital Turnover Ratio
 13.92 12.22 7.89 5.31 4.02
Cash Conversion Cycle
 26.49 46.31 55.13 36.06 34.15
Days of Sales Outstanding
 51.76 46.76 58.27 38.89 38.20
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 25.27 0.45 3.14 2.83 4.05
Operating Cycle
 51.76 46.76 58.27 38.89 38.20
Cash Flow Ratios
Operating Cash Flow Per Share
 3.40 2.34 1.09 1.46 1.83
Free Cash Flow Per Share
 3.17 2.13 0.93 0.85 1.32
CapEx Per Share
 0.23 0.21 0.17 0.61 0.51
Free Cash Flow to Operating Cash Flow
 0.93 0.91 0.85 0.58 0.72
Dividend Paid and CapEx Coverage Ratio
 12.23 6.37 4.33 0.75 2.22
Capital Expenditure Coverage Ratio
 15.04 11.34 6.50 2.39 3.58
Operating Cash Flow Coverage Ratio
 0.16 0.11 0.11 0.21 0.36
Operating Cash Flow to Sales Ratio
 0.05 0.04 0.03 0.05 0.07
Free Cash Flow Yield
8.17%8.58%2.94%2.19%4.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 61.83 54.15 34.85 29.83 29.46
Price-to-Sales (P/S) Ratio
 0.54 0.38 0.74 1.31 1.16
Price-to-Book (P/B) Ratio
 2.34 1.56 2.11 2.95 2.45
Price-to-Free Cash Flow (P/FCF) Ratio
 12.24 11.65 34.04 45.63 22.48
Price-to-Operating Cash Flow Ratio
 11.26 10.62 28.81 26.55 16.20
Price-to-Earnings Growth (PEG) Ratio
 -3.81 -1.09 -1.16 0.99 -0.81
Price-to-Fair Value
 2.34 1.56 2.11 2.95 2.45
Enterprise Value Multiple
 16.68 15.02 11.89 14.86 11.35
Enterprise Value
 2.48B 1.87B 1.69B 1.84B 1.27B
EV to EBITDA
 16.68 15.02 11.89 14.86 11.35
EV to Sales
 0.70 0.59 0.83 1.33 1.11
EV to Free Cash Flow
 16.03 17.86 38.19 46.31 21.49
EV to Operating Cash Flow
 14.96 16.29 32.32 26.95 15.49
Tangible Book Value Per Share
 -11.35 -11.75 -0.49 1.29 4.73
Shareholders’ Equity Per Share
 16.38 15.88 14.95 13.15 12.06
Tax and Other Ratios
Effective Tax Rate
 0.38 0.39 0.38 0.36 0.47
Revenue Per Share
 72.18 64.83 42.66 29.69 25.44
Net Income Per Share
 0.62 0.46 0.90 1.30 1.00
Tax Burden
 0.61 0.57 0.53 0.68 0.52
Interest Burden
 0.53 0.50 0.71 0.85 0.92
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.07 0.07 0.08 0.08 0.07
Stock-Based Compensation to Revenue
 <0.01 0.01 0.02 0.02 0.01
Income Quality
 5.39 4.76 1.05 1.18 1.80
Currency in USD